Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12116076rdf:typepubmed:Citationlld:pubmed
pubmed-article:12116076lifeskim:mentionsumls-concept:C0008059lld:lifeskim
pubmed-article:12116076lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:12116076lifeskim:mentionsumls-concept:C0023452lld:lifeskim
pubmed-article:12116076lifeskim:mentionsumls-concept:C0442027lld:lifeskim
pubmed-article:12116076lifeskim:mentionsumls-concept:C0020615lld:lifeskim
pubmed-article:12116076lifeskim:mentionsumls-concept:C0231220lld:lifeskim
pubmed-article:12116076lifeskim:mentionsumls-concept:C1268902lld:lifeskim
pubmed-article:12116076pubmed:issue1lld:pubmed
pubmed-article:12116076pubmed:dateCreated2002-7-12lld:pubmed
pubmed-article:12116076pubmed:abstractTextAntimetabolite-based continuation therapy is commonly used for childhood acute lymphoblastic leukemia (ALL) and hypoglycemia after prolonged fasting has been recently reported. We have found that spontaneous, symptomatic hypoglycemia (SH) may also occur in such patients.lld:pubmed
pubmed-article:12116076pubmed:languageenglld:pubmed
pubmed-article:12116076pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12116076pubmed:citationSubsetIMlld:pubmed
pubmed-article:12116076pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12116076pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12116076pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12116076pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12116076pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12116076pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12116076pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12116076pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12116076pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12116076pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12116076pubmed:statusMEDLINElld:pubmed
pubmed-article:12116076pubmed:monthJullld:pubmed
pubmed-article:12116076pubmed:issn0098-1532lld:pubmed
pubmed-article:12116076pubmed:authorpubmed-author:LocatelliFran...lld:pubmed
pubmed-article:12116076pubmed:authorpubmed-author:AricòMaurizio...lld:pubmed
pubmed-article:12116076pubmed:authorpubmed-author:ZiinoOttavioOlld:pubmed
pubmed-article:12116076pubmed:authorpubmed-author:RussoDeliaDlld:pubmed
pubmed-article:12116076pubmed:authorpubmed-author:OrlandoMaria...lld:pubmed
pubmed-article:12116076pubmed:authorpubmed-author:BenignoVincen...lld:pubmed
pubmed-article:12116076pubmed:copyrightInfoCopyright 2002 Wiley-Liss, Inc.lld:pubmed
pubmed-article:12116076pubmed:issnTypePrintlld:pubmed
pubmed-article:12116076pubmed:volume39lld:pubmed
pubmed-article:12116076pubmed:ownerNLMlld:pubmed
pubmed-article:12116076pubmed:authorsCompleteYlld:pubmed
pubmed-article:12116076pubmed:pagination32-4lld:pubmed
pubmed-article:12116076pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:12116076pubmed:meshHeadingpubmed-meshheading:12116076...lld:pubmed
pubmed-article:12116076pubmed:meshHeadingpubmed-meshheading:12116076...lld:pubmed
pubmed-article:12116076pubmed:meshHeadingpubmed-meshheading:12116076...lld:pubmed
pubmed-article:12116076pubmed:meshHeadingpubmed-meshheading:12116076...lld:pubmed
pubmed-article:12116076pubmed:meshHeadingpubmed-meshheading:12116076...lld:pubmed
pubmed-article:12116076pubmed:meshHeadingpubmed-meshheading:12116076...lld:pubmed
pubmed-article:12116076pubmed:meshHeadingpubmed-meshheading:12116076...lld:pubmed
pubmed-article:12116076pubmed:meshHeadingpubmed-meshheading:12116076...lld:pubmed
pubmed-article:12116076pubmed:meshHeadingpubmed-meshheading:12116076...lld:pubmed
pubmed-article:12116076pubmed:meshHeadingpubmed-meshheading:12116076...lld:pubmed
pubmed-article:12116076pubmed:meshHeadingpubmed-meshheading:12116076...lld:pubmed
pubmed-article:12116076pubmed:meshHeadingpubmed-meshheading:12116076...lld:pubmed
pubmed-article:12116076pubmed:meshHeadingpubmed-meshheading:12116076...lld:pubmed
pubmed-article:12116076pubmed:meshHeadingpubmed-meshheading:12116076...lld:pubmed
pubmed-article:12116076pubmed:meshHeadingpubmed-meshheading:12116076...lld:pubmed
pubmed-article:12116076pubmed:meshHeadingpubmed-meshheading:12116076...lld:pubmed
pubmed-article:12116076pubmed:meshHeadingpubmed-meshheading:12116076...lld:pubmed
pubmed-article:12116076pubmed:meshHeadingpubmed-meshheading:12116076...lld:pubmed
pubmed-article:12116076pubmed:meshHeadingpubmed-meshheading:12116076...lld:pubmed
pubmed-article:12116076pubmed:meshHeadingpubmed-meshheading:12116076...lld:pubmed
pubmed-article:12116076pubmed:year2002lld:pubmed
pubmed-article:12116076pubmed:articleTitleSymptomatic hypoglycemia in children receiving oral purine analogues for treatment of childhood acute lymphoblastic leukemia.lld:pubmed
pubmed-article:12116076pubmed:affiliationPediatric Hematology Oncology, Ospedale dei Bambini "G. Di Cristina, Palermo", Italy.lld:pubmed
pubmed-article:12116076pubmed:publicationTypeJournal Articlelld:pubmed